Skip to main content
Published locations for ASCO: Ipilimumab Plus Dacarbazine Prolongs Metastatic Melanoma Survival
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
ASCO: Ipilimumab Plus Dacarbazine Prolongs Metastatic Melanoma Survival
User login
Username
Password
Reset your password
/content/asco-ipilimumab-plus-dacarbazine-prolongs-metastatic-melanoma-survival
/edermatologynews/article/35473/melanoma/asco-ipilimumab-plus-dacarbazine-prolongs-metastatic
/dermatology/article/35473/melanoma/asco-ipilimumab-plus-dacarbazine-prolongs-metastatic-melanoma